Latest filing published 01 Mar 2006 for VIROPHARMA INC, €130k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Baker Biotech Capital II (Z) (GP), LLC: trading record in brief
Baker Biotech Capital II (Z) (GP), LLC is a declared insider at 2 companies; the most frequent names are Viropharma Inc and Intrabiotics Pharmaceuticals Inc /DE. In total, 7 filings cover trades dated from 24 February 2006 to 28 February 2006.
On the open market, the record shows 1 purchase worth €5,040 and 6 sales worth €555k. On balance, insiders were net sellers of €550k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The newest entry dates from 1 March 2006: an open-market sale of €130k, in Viropharma Inc. The latest purchase dates back some time: it was published 7,559 days ago, on 28 February 2006. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Baker Biotech Capital II (Z) (GP), LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,080 shares@ US$21.743Common StockSEC:0001144204-06-008357:0
- 7,165 shares@ US$21.7242Common StockSEC:0001144204-06-008357:1
- 1,606 shares@ US$21.5799Common StockSEC:0001144204-06-008357:2
- 30 shares@ US$21.8063Common StockSEC:0001144204-06-008357:3
- 10,508 shares@ US$19.8953Common StockSEC:0001144204-06-008357:4
- 5,169 shares@ US$20.4109Common StockSEC:0001144204-06-008357:5
- 1,787 shares@ US$3.35Common StockSEC:0001144204-06-007975:0Canonical exit: 25 May 2006 (T+90)
7 of 7 declarations